Despite challenges from a lower-margin product mix, Zydus Life benefitted from forex gains and a favourable tax rate, which ...

Zydus Lifesciences Ltd (BOM:532321) reports a robust 17% revenue increase and significant advancements in its innovation pipeline amidst market challenges.

Prabhudas Lilladher recommended accumulate rating on Zydus Lifesciences with a target price of Rs 1050 in its research report ...

ICICI Securities recommended hold rating on Zydus Lifesciences with a target price of Rs 1000 in its research report dated.

Zydus Lifesciences Ltd is quoting at Rs 1018.55, up 4.25% on the day as on 12:49 IST on the NSE. The stock is up 28.67% in last one year as compared to a 7.61% jump in NIFTY and a 18.78% jump in the ...

Ahead of the market opening on Friday, February 7, analysts from domestic brokerages have recommended several stocks for ...

Ipca Laboratories Ltd.(down 1.45 per cent), Sun Pharmaceutical Industries Ltd.(down 0.88 per cent), Mankind Pharma Ltd.(down ...

State Bank of India (SBI) weighed on PSU banks, with the Nifty PSU Bank index down nearly 1%. SBI shares declined 2% after ...

Today, majors including Swiggy, Info Edge India, Reliance Power, Page Industries, Kansai Nerolac Paints, Gujarat Gas, Welspun ...

The Nifty Pharma index closed on a positive note on Thursday. Shares of Abbott India Ltd.(up 4.61 per cent), Natco Pharma Ltd ...

NDTV Profit tracks what analysts are saying about various stocks and sectors. Here are the analyst calls to keep an eye out ...

The Indian stock market ended largely lower on Thursday (February 6), failing to sustain opening gains as broader indices saw ...